Opportunities and challenges for the cellular immunotherapy sector: a global landscape of clinical trials

In this Regenerative Medicine Special Report, learn more about the future of cellular immunotherapy. Global investments in cellular immunotherapies reflect their curative potential. Our landscape of clinical trials will aid developers, investors, adopters and payers in planning for adoption and implementation along realistic time horizons. Trend data enable stakeholders to adapt their business models and capacity to bring immunotherapies to the clinic. In this Special Report, originally published in Regenerative Medicine, learn more about the global landscape of clinical development in cellular immunotherapy and understand the opportunities and challenges.   Figure 3. Number of 1560 clinical trials per year from 1995—2015...